A carregar...
Striving for optimal bronchodilation: focus on olodaterol
β(2)-agonists were introduced in the 1940s as bronchodilators to be used in obstructive respiratory diseases. Long-acting β(2)-agonists have been a mainstay of bronchodilating treatment for decades. Recently, agents extending their effect to 24 hours and thus allowing the once-daily administration w...
Na minha lista:
| Publicado no: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4780202/ https://ncbi.nlm.nih.gov/pubmed/27042036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S96070 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|